Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre M Tapp

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Psychiatry|January 2, 2007
Beneficial effects of prazosin for visual hallucinations associated with chronic cocaine abuseAndre M Tapp, Annette Kennedy, Elaine R Peskind, et al.
The Annals of Pharmacotherapy|September 8, 2005
Antipsychotic polypharmacy: do benefits justify the risks?Andre M Tapp, Amanda Ernst Wood, Nael Kilzieh, et al.
Alzheimer Disease and Associated Disorders|September 5, 2014
The utility of the Dementia Severity Rating Scale in differentiating mild cognitive impairment and Alzheimer disease from controlsJoel C Mitchell, Malcolm B Dick, Amanda E Wood, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient settingNael Kilzieh, Jeffrey A Todd-Stenberg, Annette Kennedy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in ratsMurray A Raskind, Brianna L Burke, Norman J Crites, et al.
Journal of Addiction Medicine|July 20, 2011
Open trial of injectable risperidone for methamphetamine dependenceCharles W Meredith, Craig Jaffe, Monique Cherrier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Psychiatry|January 2, 2007
Beneficial effects of prazosin for visual hallucinations associated with chronic cocaine abuseAndre M Tapp, Annette Kennedy, Elaine R Peskind, et al.
The Annals of Pharmacotherapy|September 8, 2005
Antipsychotic polypharmacy: do benefits justify the risks?Andre M Tapp, Amanda Ernst Wood, Nael Kilzieh, et al.
Alzheimer Disease and Associated Disorders|September 5, 2014
The utility of the Dementia Severity Rating Scale in differentiating mild cognitive impairment and Alzheimer disease from controlsJoel C Mitchell, Malcolm B Dick, Amanda E Wood, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient settingNael Kilzieh, Jeffrey A Todd-Stenberg, Annette Kennedy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in ratsMurray A Raskind, Brianna L Burke, Norman J Crites, et al.
Journal of Addiction Medicine|July 20, 2011
Open trial of injectable risperidone for methamphetamine dependenceCharles W Meredith, Craig Jaffe, Monique Cherrier, et al.
Pageof 1